Patrick Lavery is an Editor for the MJH Life Sciences brands Pharmaceutical Technology and BioPharm International, and their respective websites, pharmtech.com and biopharminternational.com. Previously at MJH, he filled the same role for LCGC International and Spectroscopy.
PCI Pharma Services Successfully Completes International Inspection of New Hampshire Campus
August 21st 2024The International Coalition of Medicines Regulatory Authorities’ new Collaborative Hybrid Inspection Pilot program allows a CDMO to gain approval from multiple countries simultaneously, as opposed to separately phased inspections from different corners of the globe.
Severe Eosinophilic Asthma Maintenance Treatment Approved in China for Ages 12 and Up
August 20th 2024Fasenra, which has been approved since 2019 in the United States in a pre-filled, single-use auto-injector form that can be administered either in a doctor’s office or at home, is now approved in China for age 12 and up.
Lonza Adds Bottling, Labeling Capabilities to Clinical Manufacturing Services at US Site
August 6th 2024The new additions to the company’s equipment at its early phase clinical manufacturing facility in Oregon will allow for cleaning, filling, capping, and sealing, and also detecting defects in drug products.
FDA Draft Guidance Seeks to Support Drug Developers for Pediatric Inflammatory Bowel Disease
July 23rd 2024While the document does not address treatment or prevention of the long-term complications of ulcerative colitis or Crohn’s disease in children, it aims to help sponsors developing drugs for pediatric patients currently affected.